Our founders, Thomas Large and Kerry Spear, are drug hunters and internationally recognized experts in systems neuroscience, molecular biology, and medicinal chemistry. Both have held leadership roles at major CNS pharmaceutical companies such as Eli Lilly and Sunovion.
Blue Oak is guided and advised by experienced drug hunters and biotech business leaders whose collective expertise has been essential in our efforts to reinvent pharmaceutical R&D for brain disorders.
For investment or partnership opportunities or to learn more about our clinical programs, contact our team today.
CONTACT US